794535-32-3

Basic information

• Product Name: (+/-)-{4-[1-(4-chlorophenyl)ethyl]-7-fluoro-5-(methanesulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl}acetic acid
• Synonyms: (+/-)-{4-[1-(4-chlorophenyl)ethyl]-7-fluoro-5-(methanesulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl}acetic acid
• CAS NO: 794535-32-3
• Molecular Weight: 449.93
• Mol File: 794535-32-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (+/-)-{4-[1-(4-chlorophenyl)ethyl]-7-fluoro-5-(methanesulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl}acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (+/-)-{4-[1-(4-chlorophenyl)ethyl]-7-fluoro-5-(methanesulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl}acetic acid(794535-32-3)
• EPA Substance Registry System: (+/-)-{4-[1-(4-chlorophenyl)ethyl]-7-fluoro-5-(methanesulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl}acetic acid(794535-32-3)

Safety Data

• Hazardous Substances Data: 794535-32-3(Hazardous Substances Data)

Upstream product

• 393509-23-4 (5-bromo-7-fluoro-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid 
• 186581-53-3 diazomethane 
• 14804-61-6 1-(1-bromoethyl)-4-chlorobenzene 
• 7787-70-4 copper(I) bromide 

Relevant articles and documents

NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT

The present invention encompasses compounds of Formula (I); as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating dyslipidemias. Pharmaceutical compositions and methods of use are also included.